Literature DB >> 10668471

Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis.

J H Hager1, D Hanahan.   

Abstract

Apoptosis, the process of programmed cell death, plays a critical role in many normal and pathological (disease) processes. In normal tissues, apoptosis functions in the homeostatic maintenance of proper tissue and organ size by eliminating aged cells to offset the birth of new cells that arise by mitosis. In disease, apoptosis can affect the pathological process is two disparate ways. There are diseases that have too much apoptosis such as autoimmune diabetes and Alzheimer's, or those that have too little apoptosis, such as cancer. This review will focus on the latter and, more specifically, detail and summarize some important lessons learned about apoptosis and cancer from studying a transgenic mouse model of islet cell carcinoma, RIP-Tag, as outlined below.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668471     DOI: 10.1111/j.1749-6632.1999.tb07929.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

1.  Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.

Authors:  Deirdre A Buckley; Alan Cheng; Patrick A Kiely; Michel L Tremblay; Rosemary O'Connor
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 2.  Genetically engineered mouse models in cancer research.

Authors:  Jessica C Walrath; Jessica J Hawes; Terry Van Dyke; Karlyne M Reilly
Journal:  Adv Cancer Res       Date:  2010       Impact factor: 6.242

3.  Ring1b bookmarks genes in pancreatic embryonic progenitors for repression in adult β cells.

Authors:  Joris van Arensbergen; Javier García-Hurtado; Miguel Angel Maestro; Miguel Correa-Tapia; Guy A Rutter; Miguel Vidal; Jorge Ferrer
Journal:  Genes Dev       Date:  2012-12-27       Impact factor: 11.361

4.  Of mice and MEN1: Insulinomas in a conditional mouse knockout.

Authors:  Judy S Crabtree; Peter C Scacheri; Jerrold M Ward; Sara R McNally; Gary P Swain; Cristina Montagna; Jeffrey H Hager; Douglas Hanahan; Helena Edlund; Mark A Magnuson; Lisa Garrett-Beal; A Lee Burns; Thomas Ried; Settara C Chandrasekharappa; Stephen J Marx; Allen M Spiegel; Francis S Collins
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

5.  Essential role of the small GTPase Ran in postnatal pancreatic islet development.

Authors:  Fang Xia; Takehiko Dohi; Nina M Martin; Christopher M Raskett; Qin Liu; Dario C Altieri
Journal:  PLoS One       Date:  2011-11-17       Impact factor: 3.240

Review 6.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

7.  Andrographolide suppress tumor growth by inhibiting TLR4/NF-κB signaling activation in insulinoma.

Authors:  Qian-Qian Zhang; Yi Ding; Yan Lei; Cui-Ling Qi; Xiao-Dong He; Tian Lan; Jiang-Chao Li; Ping Gong; Xuesong Yang; Jian-Guo Geng; Li-Jing Wang
Journal:  Int J Biol Sci       Date:  2014-03-21       Impact factor: 6.580

8.  Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion.

Authors:  Yi-Chieh Nancy Du; Brian C Lewis; Douglas Hanahan; Harold Varmus
Journal:  PLoS Biol       Date:  2007-10-16       Impact factor: 8.029

Review 9.  Apoptotic pathways in pancreatic ductal adenocarcinoma.

Authors:  Rainer Hamacher; Roland M Schmid; Dieter Saur; Günter Schneider
Journal:  Mol Cancer       Date:  2008-07-24       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.